Seegene Inc (096530) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.035x

Based on the latest financial reports, Seegene Inc (096530) has a cash flow conversion efficiency ratio of 0.035x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩36.26 Billion ≈ $24.57 Million USD) by net assets (₩1.04 Trillion ≈ $704.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Seegene Inc stock valuation for the company's overall valuation and market capitalisation.

Seegene Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Seegene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Seegene Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seegene Inc ranked by their cash flow conversion efficiency. Explore 096530 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Scandi Standard publ AB ST:SCST	0.111x
Guilin Sanjin Pharmaceutical Co Ltd SHE:002275	0.036x
Burke & Herbert Financial Services Corp. Common Stock NASDAQ:BHRB	0.046x
FS Credit Opportunities Corp. NYSE:FSCO	N/A
Ye Chiu Metal Recycling China Ltd SHG:601388	-0.026x
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	0.005x
Altareit PA:AREIT	0.051x
Helix Energy Solutions Group Inc NYSE:HLX	0.015x

Annual Cash Flow Conversion Efficiency for Seegene Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Seegene Inc from 2012 to 2025. View 096530 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩1.02 Trillion ≈ $688.40 Million	₩149.33 Billion ≈ $101.20 Million	0.147x	+68.97%
2024-12-31	₩981.48 Billion ≈ $665.13 Million	₩85.39 Billion ≈ $57.87 Million	0.087x	-5.57%
2023-12-31	₩1.03 Trillion ≈ $698.29 Million	₩94.93 Billion ≈ $64.33 Million	0.092x	-66.85%
2022-12-31	₩1.15 Trillion ≈ $777.83 Million	₩319.01 Billion ≈ $216.19 Million	0.278x	-10.02%
2021-12-31	₩1.08 Trillion ≈ $732.85 Million	₩334.02 Billion ≈ $226.36 Million	0.309x	-47.98%
2020-12-31	₩645.32 Billion ≈ $437.32 Million	₩383.16 Billion ≈ $259.66 Million	0.594x	+233.73%
2019-12-31	₩152.55 Billion ≈ $103.38 Million	₩27.14 Billion ≈ $18.39 Million	0.178x	+62.59%
2018-12-31	₩128.03 Billion ≈ $86.76 Million	₩14.01 Billion ≈ $9.49 Million	0.109x	+35.27%
2017-12-31	₩125.04 Billion ≈ $84.74 Million	₩10.12 Billion ≈ $6.86 Million	0.081x	-30.63%
2016-12-31	₩141.97 Billion ≈ $96.21 Million	₩16.56 Billion ≈ $11.22 Million	0.117x	+612.54%
2015-12-31	₩135.09 Billion ≈ $91.55 Million	₩-3.07 Billion ≈ $-2.08 Million	-0.023x	-131.84%
2014-12-31	₩94.83 Billion ≈ $64.27 Million	₩6.78 Billion ≈ $4.59 Million	0.071x	+308.60%
2013-12-31	₩84.44 Billion ≈ $57.23 Million	₩-2.89 Billion ≈ $-1.96 Million	-0.034x	-139.12%
2012-12-31	₩41.94 Billion ≈ $28.42 Million	₩3.67 Billion ≈ $2.49 Million	0.088x	--

About Seegene Inc

KQ:096530 Korea Biotechnology

Market Cap

$1.04 Billion

₩1.54 Trillion KRW

Market Cap Rank

#8731 Global

#225 in Korea

Share Price

₩33700.00

Change (1 day)

+3.85%

52-Week Range

₩21850.00 - ₩35650.00

All Time High

₩140042.88